Korczynski Sherry — SEC Form 4 filings
SEC reporting owner CIK 2026090. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-11 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 24,491 shares, $111,362 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 15,741 shares @ $4.17 ($65,687) in Aquestive Therapeutics, Inc., filed 2026-03-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 9 | — | 2 legs · 24,491 sh · $111,362 | 13 |
Form 4 filings — Korczynski Sherry
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Option exercise (M): 8,750 @ $2.65 · Sale (S): 8,750 @ $5.22 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2026-08-17 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 2,714 @ $4.25 | EDGAR |
| 2026-06-09 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 2,714 @ $0 | EDGAR |
| 2026-04-13 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 67,500 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 75,000 @ $0 · Sale (S): 15,741 @ $4.17 · Grant/award (A): 42,500 (derivative) @ $4.29 | EDGAR |
| 2025-08-15 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2025-06-10 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 2,714 @ $3.54 | EDGAR |
| 2025-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 90,000 @ $0 · Tax withholding (F): 5,428 @ $2.65 · Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 25,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2026090 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →